Decades of lab tests have proven that gene therapy has the potential to treat blindness caused by retinitis pigmentosa (RP) and related retinal dystrophies. For this potential to be realised, however, the lab tests must be developed and made safe for clinical trials on real people.
RP Fighting Blindness has committed to investing a total of £750,000 into RP gene therapy research at UCL Institute of Ophthalmology. Of this, £145,090 is committed to year 2 of the project and to fund this portion the charity ran the second phase of the Gene Team appeal up until July 2013.
The project is intended to translate the scientific advances made over recent years into clinical trials and potential treatments. The project is led by eminent researcher Professor Robin Ali who has built an outstanding team of scientists around him.
Watch the interview below of Professor Robin Ali explaining the exciting progress the Gene Team has made so far.
Will you send a donation to help us meet our target and help the Gene Team prepare for and run clinical trials?